News
After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...
The attorney general is purging the Justice Department of employees connected to the Jan. 6 prosecutions, and the ...
4h
Zacks Investment Research on MSNFDA Accepts GSK Filing for Expanded Use of RSV Shot in Younger AdultsGSK plc GSK announced that the FDA has accepted its regulatory filing seeking to expand the use of its RSV vaccine, Arexvy, in adults under 50 who are at a higher risk of the disease. A final decision ...
5h
Zacks Investment Research on MSNInvestors Heavily Search Pfizer Inc. (PFE): Here is What You Need to KnowPfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...
Most of America was blissfully unaware of the havoc wreaked by urban renewal until Kelo, when the veil was lifted. Anybody’s ...
Nurix Therapeutics shows strong BTK degrader data and key pharma ties, with risks but solid long-term potential. Find out why ...
Pfizer Inc. (NYSE: PFE) is one of the 13 Best Large Cap Stocks to Buy Right Now. On July 10, Pfizer Inc. (NYSE:PFE) shared ...
Each week on LinkedIn, business leaders announce moves to and from companies that play a role in our daily lives. See notable ...
A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...
In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...
Pfizer faces adjusted financial forecasts as analysts lower earnings expectations for FY2025, signaling cautious optimism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results